uracil has been researched along with Eczema, Atopic in 4 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, compound 13d, having potent hydroxyl radical-scavenging activity, showed more potent suppressive effect on substance P-induced pruritus in mice than oxatomide." | 3.83 | Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases. ( Fujiwara, N; Hasegawa, F; Inoue, Y; Isobe, M; Isobe, Y; Tobe, M; Tsuboi, K, 2016) |
| " Although topical corticosteroids have been widely utilized in steroid-responsive dermatoses such as AD, their chronic use may be associated with significant side effects." | 1.32 | Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. ( Hayashi, H; Inoue, Y; Isobe, M; Shiohara, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tobe, M | 1 |
| Tsuboi, K | 1 |
| Hasegawa, F | 1 |
| Fujiwara, N | 1 |
| Inoue, Y | 2 |
| Isobe, M | 2 |
| Isobe, Y | 1 |
| Shiohara, T | 1 |
| Hayashi, H | 1 |
| Potekaev, NS | 1 |
| Sevidova, LIu | 2 |
| Vladimirov, VV | 1 |
| Kochergin, NG | 2 |
| Shinaev, NN | 2 |
| Belokrinitskiĭ, VV | 1 |
| Shelepin, AA | 1 |
4 other studies available for uracil and Eczema, Atopic
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Benzofurans; Cell Line, Tumor; Cell Membran | 2016 |
Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Atopic; Der | 2003 |
[Selective phototherapy and immunocorrection with dimotsifon in atopic dermatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Combined Modality Therapy; Dapsone; Dermatitis, Atopic; D | 1987 |
[Therapeutic efficacy of dimocifon in atopic dermatitis].
Topics: Adolescent; Adult; Dapsone; Dermatitis, Atopic; Drug Combinations; Female; Humans; Male; Uracil | 1986 |